New Delhi, 19 November 2024: Parkinson’s disease (PD) is becoming increasingly prevalent. With estimates suggesting a rise from 2.64 million diagnosed cases in 2023 to 3.15 million by 2033. This worrying trend, shown in a recent report from GlobalData, indicates an annual growth rate of 1.94%. The report highlights that seven major countries, including the US, France, Germany, Italy, Spain, the UK, and Japan, will face a notable increase in cases. It’s vital for healthcare systems worldwide to understand the reasons behind this increase and its implications.
The report reveals that the United States projected to have the highest number of diagnosed cases, reaching approximately 1.24 million. This highlights a serious public health challenge posed by PD in the US. Conversely, Italy anticipated to have the lowest number of cases at around 0.16 million. Such differences illustrate how PD affects nations differently, influenced by factors like population demographics and health care capabilities.
Older Adults at Greater Risk
The report indicates that adults aged 60 and older now make up over 90% of PD cases in 2023, while those aged 18-39 count for less than 1%. This age distribution aligns with other research showing a higher incidence of PD among older individuals. As the global population continues to age, more people will likely be at risk of developing this neurodegenerative disorder.
Gender Differences in Diagnosis
Interestingly, the findings show a slight predominance of Parkinson’s diagnoses among men. This gender imbalance could be due to various factors, including demographic differences and how PD manifests in different populations. Recognizing these distinctions is crucial for crafting focused interventions and treatment plans for both genders affected by the disease.
Understanding Parkinson’s Disease
Parkinson’s disease is classified as an incurable neurodegenerative disorder primarily recognized for its movement-related symptoms, such as tremors, stiffness, and slow movements. As the second most prevalent chronic progressive neurodegenerative disorder after Alzheimer’s disease, PD poses significant challenges for those afflicted and their families.
Current Treatment Landscape
Managing Symptoms, Not Curing the Disease
While existing treatments can alleviate symptoms, there remains no cure to halt or slow Parkinson’s disease progression. This shortcoming underlines the critical need for continuous research and development of effective therapies. As the number of diagnosed cases grows, the need for innovative treatment solutions will become increasingly urgent.
Read Also – Experts Warn: Air Pollution Can Trigger Heart Attacks, Here’s How PM2.5 Can Cause Damage Arteries
Given that PD primarily affects older adults, countries with rising ageing populations must devise comprehensive strategies to meet the healthcare needs of these individuals. Rahul N Ravi, Senior Epidemiologist at GlobalData, stresses proactive approaches in healthcare planning. Over the next decade, the seven countries identified as most at risk for PD will play a crucial role in shaping treatment and care strategies for those affected.
